A novel calpastatin-based inhibitor improves postischemic neurological recovery

Biochemical and Biophysical Research Communications

Volumn 385, Issue 1, 2009, Pages 94-99

  Anagli, John ^a   Han, Yuxia ^a   Stewart, Laura ^a   Yang, Dongmei ^a   Movsisyan, Ashkhen ^a   Abounit, Kadija ^a   Seyfried, Donald ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Calpain; Calpastatin; Middle cerebral artery occlusion; Neurological recovery; Protease inhibitor; Rat

Indexed keywords

B 27 HYD; CALPAIN; CYSTEINE PROTEINASE INHIBITOR; FODRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; HISTOPATHOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CALCIUM-BINDING PROTEINS; CALPAIN; CEREBRAL INFARCTION; CYSTEINE PROTEINASE INHIBITORS; DISEASE MODELS, ANIMAL; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; SPECTRIN;

ANIMALIA; RATTUS;

EID: 67349156046     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.141     Document Type: Article

References (49)

1. WHO, The World Health Report 2004. Available from: .
2. Rosalind W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update. Circulation 115 (2007) e99-e110
3. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol. Rev. 83 (2003) 731-801
4. Franco S.J., and Huttenlocher A. Regulating cell migration: calpains make the cut. J. Cell Sci. 118 (2005) 3829-3838
5. Wu M., Yu Z., Fan J., Caron A., Whiteway M., and Shen S.H. Functional dissection of human protease mu-calpain in cell migration using RNAi. FEBS Lett. 580 (2006) 3246-3256
6. Abe K., and Takeichi M. NMDA-receptor activation induces calpain-mediated beta-catenin cleavages for triggering gene expression. Neuron 53 (2007) 387-397
7. Croall D.E., and Ersfeld K. The calpains: modular designs and functional diversity. Genome Biol. 8 (2007) 218
8. Camins A., Verdaguer E., Folch J., and Pallas M. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev. 12 (2006) 135-148
9. Bertipaglia I., and Carafoli E. Calpains and human disease. Subcell. Biochem. 45 (2007) 29-53
10. Bevers M.B., and Neumar R.W. Mechanistic role of calpains in postischemic neurodegeneration. J. Cereb. Blood Flow Metab. (2007) 1-19
11. Vosler P.S., Brennan C.S., and Chen J. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol. Neurobiol. 38 (2008) 78-100
12. Liu J., Liu M.C., and Wang K.K.W. Calpain in the CNS: from synaptic function to neurotoxicity. Sci. Signal 1 (2008) re1
13. Samantaray S., Ray S.K., and L Banik N. Calpain as a potential therapeutic target in Parkinson's disease. CNS Neurol. Disord. Drug Targets 7 (2008) 305-312
14. Siesjo B.K., and Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9 (1989) 127-140
15. 2+ signals and neuronal death in brain ischemia. Stroke 38 (2007) 674-676
16. Bullock R., and Fujisawa H. The role of glutamate antagonists for the treatment of CNS injury. J. Neurotrauma 9 (1992) S443-462
17. Wang K., and Yuen P.O. Calpain substrates, assay methods, regulation and its inhibitory agents. In: Wang K.K.W., and Yuen P. (Eds). Calpain: Pharmacology and Toxicology of Calcium-dependent Protease (1999), Taylor & Francis, Philadelphia, PA 77-102
18. Donkor I.O. A survey of calpain inhibitors. Curr. Med. Chem. 7 (2000) 1171-1188
19. Ray S.K. Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia. Curr. Med. Chem. 13 (2006) 3425-3440
20. Donkor I.O., Assefa H., and Liu J. Structural basis for the potent calpain inhibitory activity of peptidyl alpha-ketoacids. J. Med. Chem. 51 (2008) 4346-4350
21. Koumura A., Nonaka Y., Hyakkoku K., Oda T., Shimazawa M., Hozumi I., Inuzuka T., and Hara H. A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-dioxopropyl)amino)carbonyl)-3-methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice. Neuroscience 157 (2008) 309-318
22. Betts R., Weinsheimer S., Blouse G., and Anagli J. Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT. J. Biol. Chem. 278 (2003) 7800-7809
23. 18 side chains play a direct role in calpain inhibition. Biochemistry 43 (2004) 2596-2604
24. Wendt A., Thompson V.F., and Goll D.E. Interaction of calpastatin with calpain: a review. Biol. Chem. 385 (2004) 465-472
25. Gil-Parrado S., Assfalg-Machleidt I., Fiorino F., Deluca D., Pfeiler D., Schaschke N., Moroder L., and Machleidt W. Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin. Biol. Chem. 384 (2003) 395-402
26. Pfizer J., Assfalg-Machleidt I., Machleidt W., and Schaschke N. Inhibition of human μ-calpain by conformationally constrained calpastatin peptides. Biol. Chem. 389 (2008) 83-90
27. Moldoveanu T., Gehring K., and Green D.R. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains. Nature 456 (2008) 404-408
28. Hanna R.A., Campbell R.L., and Davies P.L. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature 456 (2008) 409-413
29. Zea Longa E., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
30. Seyfried D.M., Veyna R., Han Y., Li K., Tang N., Betts R.L., Weinsheimer S., Chopp M., and Anagli J. A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia. Brain Res. 901 (2001) 94-101
31. Anagli J., Abounit K., Stemmer P., Han Y., Allred L., Weinsheimer S., Movsisyan A., and Seyfried D. Effects of cathepsin B and L inhibition on postischemic protein alterations in the brain. Biochem. Biophys. Res. Commun. 366 (2008) 86-91
32. B Bederson J., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., and Bartowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination. Stroke 17 (1986) 472-476
33. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
34. Towbin H., Staehelin T., and Gordon J. Electrophoresis transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76 (1970) 4350-4354
35. Veach R.A., Liu D., Yao S., Chen Y., Liu X.Y., Downs S., and Hawiger J. Receptor/transporter-independent targeting of functional peptides across the plasma membrane. J. Biol. Chem. 279 (2004) 11425-11431
36. Brock T.O., and O'Callaghan J.P. Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous system. J. Neurosci. 7 (1987) 931-942
37. Bendotti C., Baldessari S., Pende M., Southgate T., Guglielmetti F., and Samanin R. Relationship between GAP-43 expression in the dentate gyrus and synaptic reorganization of hippocampal mossy fibres in rats treated with kainic acid. Eur. J. Neurosci. 9 (1997) 93-101
38. Emery D.L., Raghupathi R., Saatman K.E., Fisher I., Grady M.S., and McIntosh T.K. Bilateral growth-related protein expression suggests a transient increase in regenerative potential following brain trauma. J. Comp. Neurol. 424 (2000) 521-531
39. Thompson S.N., Gibson T.R., Thompson B.M., Deng Y., and Hall E.D. Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury. Exp. Neurol. 201 (2006) 253-265
40. Chen A., Liao W.P., Lu Q., Wong W.S.F., and Wong P.T.H. Upregulation of dihydropyrimidinase-related protein 2, spectrin αII chain, heat shock cognate protein 70 pseudogene 1, and tropomodulin 2 after focal cerebral ischemia in rats-A proteomics approach. Neurochem. Int. 50 (2006) 1078-1086
41. Hou S.T., Jiang S.X., Desbois A., Huang D., Kelly J., Tessier L., Karchewski L., and Kappler J. Calpain-cleaved collapsing response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia. J. Neurosci. 26 (2006) 2241-2249
42. Jiang S.X., Kappler J., Zurakowski B., Desbois A., Aylsworth A., and Hou S.T. Calpain cleavage of collapsin response mediator proteins in ischemic mouse brain. Eur. J. Neurosci. 26 (2007) 801-809
43. Stroemer R.P., Kent T.A., and Hulsebosch C.E. Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke 26 (1995) 2135-2144
44. Hurtado O., Pradillo J.M., Alonso-Escolano D., Lorenzo P., Sobrino T., Castillo J., Lizasoain I., and Moro M.A. Neurorepair versus neuroprotection in stroke. Cerebrovasc. Dis. 21 (2006) 54-63
45. Di Filippo M., Tozzi A., Costa C., Belcastro V., Tantucci M., Piconni B., and Calabresi P. Plasticity and repair in the post-ischemic brain. Neuropharmacology 55 (2008) 353-362
46. Hou S.T., Jiang S.X., and Smith R.A. Permissive and repulsive cues and signaling pathways of axonal outgrowth and regeneration. Int. Rev. Cell Mol. Biol. 267 (2008) 125-181
47. Pike B., Flint J., Dave J.R., Lu X.-C.M., Wang K.K.K., Tortella F.C., and Hayes R.L. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived αII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J. Cereb Blood Flow Metab. 24 (2003) 98-106
48. Cardali S., and Maugeri R. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury. J. Neurosurg. Sci. 50 (2006) 25-31
49. Pineda J.A., Lewis S.B., Valadka A.B., Papa L., Hannay H.J., Heaton S.C., Demery J.A., Liu M.C., Aikman J.M., Akle V., Brophy G.M., Tepas III J.J., Wang K.K.W., Robertson C.S., and Hayes R.L. Clinical significance of αII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24 (2007) 354-366